AFP ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM— 510(k) K020807

Name: FDA 510(k) clearance K020807
Creator: U.S. Food and Drug Administration
Published: 2002-10-01

Substantially Equivalent

Bayer Diagnostics Corp.

FDA 510(k) clearance K020807 for AFP ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM, Substantially Equivalent on 2002-10-01. Applicant: Bayer Diagnostics Corp.. Device class: 2.

Clearance details

Applicant: Bayer Diagnostics Corp.
Product code: Code LOJ
Device class: Class 2
Regulation: 21 CFR 866.6010
Advisory panel: Immunology
Date received: 2002-03-12
Decision date: 2002-10-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LOJ

view all

K220176 — Elecsys AFP2022-09-15
K213626 — VITROS AFP2022-06-15
K090236 — DIMENSION VISTA AFP FLEX REAGENT CARTRIDGE, MODEL 64542009-04-27
K081709 — OLYMPUS AFP - ALPHA-FETOPROTEIN2009-03-16
K080017 — VIDAS AFP ASSAY2008-09-26

More clearances from Bayer Diagnostics Corp.

view all

K033379 — BAYER SPECIAL CHEMISTRY CONTROLS2003-12-19
K033380 — BAYER SPECIAL CHEMISTRY CALIBRATORS2003-12-16
K033007 — BAYER ADVIA DIGOXIN ASSAY FOR THE INTEGRATED MODULE SYSTEM2003-11-14
K031857 — ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAY2003-09-04
K022096 — URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM2003-03-18

Data sourced from openFDA. This site is unofficial and independent of the FDA.